These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

685 related articles for article (PubMed ID: 31091372)

  • 21. The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: the RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy).
    Reilly PA; Lehr T; Haertter S; Connolly SJ; Yusuf S; Eikelboom JW; Ezekowitz MD; Nehmiz G; Wang S; Wallentin L;
    J Am Coll Cardiol; 2014 Feb; 63(4):321-8. PubMed ID: 24076487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of clopidogrel added to aspirin in patients with recent lacunar stroke.
    ; Benavente OR; Hart RG; McClure LA; Szychowski JM; Coffey CS; Pearce LA
    N Engl J Med; 2012 Aug; 367(9):817-25. PubMed ID: 22931315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rivaroxaban versus aspirin on functional and cognitive outcomes after embolic stroke of undetermined source: NAVIGATE ESUS trial.
    Bosch J; Pearce LA; Sharma M; Canavan M; Whiteley WN; Mikulík R; Mundl H; Yusuf S; Hart RG; O'Donnell MJ
    J Stroke Cerebrovasc Dis; 2022 May; 31(5):106404. PubMed ID: 35292423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of Patients with Embolic Strokes of Undetermined Source in the NAVIGATE ESUS Randomized Trial.
    Kasner SE; Lavados P; Sharma M; Wang Y; Wang Y; Dávalos A; Shamalov N; Cunha L; Lindgren A; Mikulik R; Arauz A; Lang W; Czlonkowska A; Eckstein J; Gagliardi R; Amarenco P; Ameriso SF; Tatlisumak T; Veltkamp R; Hankey GJ; Toni DS; Bereczki D; Uchiyama S; Ntaios G; Yoon BW; Brouns R; DeVries Basson MM; Endres M; Muir K; Bornstein N; Ozturk S; O'Donnell M; Mundl H; Pater C; Weitz J; Peacock WF; Swaminathan B; Kirsch B; Berkowitz SD; Peters G; Pare G; Themeles E; Shoamanesh A; Connolly SJ; Hart RG;
    J Stroke Cerebrovasc Dis; 2018 Jun; 27(6):1673-1682. PubMed ID: 29525076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rivaroxaban versus aspirin for secondary prevention of ischaemic stroke in patients with cancer: a subgroup analysis of the NAVIGATE ESUS randomized trial.
    Martinez-Majander N; Ntaios G; Liu YY; Ylikotila P; Joensuu H; Saarinen J; Perera KS; Marti-Fabregas J; Chamorro A; Rudilosso S; Prats-Sanchez L; Berkowitz SD; Mundl H; Themeles E; Tiainen M; Demchuk A; Kasner SE; Hart RG; Tatlisumak T;
    Eur J Neurol; 2020 May; 27(5):841-848. PubMed ID: 32056346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and Safety of Rivaroxaban Versus Aspirin in Embolic Stroke of Undetermined Source and Carotid Atherosclerosis.
    Ntaios G; Swaminathan B; Berkowitz SD; Gagliardi RJ; Lang W; Siegler JE; Lavados P; Mundl H; Bornstein N; Meseguer E; Amarenco P; Cucchiara B; Camps-Renom P; Makaritsis K; Korompoki E; Papavasileiou V; Marti-Fabregas J; Milionis H; Vemmos K; Connolly SJ; Hart RG;
    Stroke; 2019 Sep; 50(9):2477-2485. PubMed ID: 31401971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frequency and Predictors of Major Bleeding in Patients With Embolic Strokes of Undetermined Source: NAVIGATE-ESUS Trial.
    Mikulík R; Eckstein J; Pearce LA; Mundl H; Rudilosso S; Olavarría VV; Shoamanesh A; Chamorro Á; Martí-Fàbregas J; Veltkamp R; Öztürk Ş; Tatlisumak T; Peacock WF; Berkowitz SD; Connolly SJ; Hart RG
    Stroke; 2020 Jul; 51(7):2139-2147. PubMed ID: 32517582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rivaroxaban versus aspirin for prevention of covert brain infarcts in patients with embolic stroke of undetermined source: NAVIGATE ESUS MRI substudy.
    Sharma M; Smith EE; Pearce LA; Perera KS; Kasner SE; Yoon BW; Ameriso SF; Puig J; Damgaard D; Fiebach JB; Muir KW; Veltkamp RC; Toni DS; Shamalov N; Gagliardi RJ; Mikulik R; Engelter ST; Bereczki D; O'Donnell MJ; Saad F; Shoamanesh A; Berkowitz SD; Mundl H; Hart RG;
    Int J Stroke; 2022 Aug; 17(7):799-805. PubMed ID: 34791941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Burden of oral anticoagulation in embolic stroke of undetermined source without atrial fibrillation.
    Witte KK; Tsivgoulis G; Reynolds MR; Tsintzos SI; Eggington S; Ismyrloglou E; Lyon J; Huynh M; Egea M; de Brouwer B; Ziegler PD; Franco N; Joglekar R; Rosemas SC; Liu S; Thijs V
    BMC Cardiovasc Disord; 2021 Mar; 21(1):160. PubMed ID: 33789592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low-dose aspirin for preventing recurrent venous thromboembolism.
    Brighton TA; Eikelboom JW; Mann K; Mister R; Gallus A; Ockelford P; Gibbs H; Hague W; Xavier D; Diaz R; Kirby A; Simes J;
    N Engl J Med; 2012 Nov; 367(21):1979-87. PubMed ID: 23121403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism.
    Weitz JI; Lensing AWA; Prins MH; Bauersachs R; Beyer-Westendorf J; Bounameaux H; Brighton TA; Cohen AT; Davidson BL; Decousus H; Freitas MCS; Holberg G; Kakkar AK; Haskell L; van Bellen B; Pap AF; Berkowitz SD; Verhamme P; Wells PS; Prandoni P;
    N Engl J Med; 2017 Mar; 376(13):1211-1222. PubMed ID: 28316279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial.
    Kasner SE; Swaminathan B; Lavados P; Sharma M; Muir K; Veltkamp R; Ameriso SF; Endres M; Lutsep H; Messé SR; Spence JD; Nedeltechev K; Perera K; Santo G; Olavarria V; Lindgren A; Bangdiwala S; Shoamanesh A; Berkowitz SD; Mundl H; Connolly SJ; Hart RG;
    Lancet Neurol; 2018 Dec; 17(12):1053-1060. PubMed ID: 30274772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation.
    Cannon CP; Bhatt DL; Oldgren J; Lip GYH; Ellis SG; Kimura T; Maeng M; Merkely B; Zeymer U; Gropper S; Nordaby M; Kleine E; Harper R; Manassie J; Januzzi JL; Ten Berg JM; Steg PG; Hohnloser SH;
    N Engl J Med; 2017 Oct; 377(16):1513-1524. PubMed ID: 28844193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microbleeds and the Effect of Anticoagulation in Patients With Embolic Stroke of Undetermined Source: An Exploratory Analysis of the NAVIGATE ESUS Randomized Clinical Trial.
    Shoamanesh A; Hart RG; Connolly SJ; Kasner SE; Smith EE; Martí-Fàbregas J; Liu YY; Uchiyama S; Mikulik R; Veltkamp R; O'Donnell MJ; Ntaios G; Muir KW; Field TS; Santo GC; Olavarria V; Mundl H; Lutsep H; Berkowitz SD; Sharma M
    JAMA Neurol; 2021 Jan; 78(1):11-20. PubMed ID: 33074284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ticagrelor Versus Aspirin in Acute Embolic Stroke of Undetermined Source.
    Amarenco P; Albers GW; Denison H; Easton JD; Evans SR; Held P; Hill MD; Jonasson J; Kasner SE; Ladenvall P; Minematsu K; Molina CA; Wang Y; Wong KSL; Johnston SC;
    Stroke; 2017 Sep; 48(9):2480-2487. PubMed ID: 28720658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ticagrelor and Aspirin or Aspirin Alone in Acute Ischemic Stroke or TIA.
    Johnston SC; Amarenco P; Denison H; Evans SR; Himmelmann A; James S; Knutsson M; Ladenvall P; Molina CA; Wang Y;
    N Engl J Med; 2020 Jul; 383(3):207-217. PubMed ID: 32668111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recurrent Stroke With Rivaroxaban Compared With Aspirin According to Predictors of Atrial Fibrillation: Secondary Analysis of the NAVIGATE ESUS Randomized Clinical Trial.
    Healey JS; Gladstone DJ; Swaminathan B; Eckstein J; Mundl H; Epstein AE; Haeusler KG; Mikulik R; Kasner SE; Toni D; Arauz A; Ntaios G; Hankey GJ; Perera K; Pagola J; Shuaib A; Lutsep H; Yang X; Uchiyama S; Endres M; Coutts SB; Karlinski M; Czlonkowska A; Molina CA; Santo G; Berkowitz SD; Hart RG; Connolly SJ
    JAMA Neurol; 2019 Jul; 76(7):764-773. PubMed ID: 30958508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Embolic strokes of undetermined source: theoretical construct or useful clinical tool?
    Tsivgoulis G; Katsanos AH; Köhrmann M; Caso V; Lemmens R; Tsioufis K; Paraskevas GP; Bornstein NM; Schellinger PD; Alexandrov AV; Krogias C
    Ther Adv Neurol Disord; 2019; 12():1756286419851381. PubMed ID: 31205494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Long-Term Multicenter Observational Study of Dabigatran Treatment in Patients With Atrial Fibrillation (RELY-ABLE) Study.
    Connolly SJ; Wallentin L; Ezekowitz MD; Eikelboom J; Oldgren J; Reilly PA; Brueckmann M; Pogue J; Alings M; Amerena JV; Avezum A; Baumgartner I; Budaj AJ; Chen JH; Dans AL; Darius H; Di Pasquale G; Ferreira J; Flaker GC; Flather MD; Franzosi MG; Golitsyn SP; Halon DA; Heidbuchel H; Hohnloser SH; Huber K; Jansky P; Kamensky G; Keltai M; Kim SS; Lau CP; Le Heuzey JY; Lewis BS; Liu L; Nanas J; Omar R; Pais P; Pedersen KE; Piegas LS; Raev D; Smith PJ; Talajic M; Tan RS; Tanomsup S; Toivonen L; Vinereanu D; Xavier D; Zhu J; Wang SQ; Duffy CO; Themeles E; Yusuf S
    Circulation; 2013 Jul; 128(3):237-43. PubMed ID: 23770747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dabigatran versus aspirin for stroke prevention after cryptogenic stroke with patent foramen ovale: A prospective study.
    Chen S; Cai D; Lai Y; He J; Wu Q; Huang P; Zhou L; Sun H
    Clin Neurol Neurosurg; 2022 Apr; 215():107189. PubMed ID: 35231678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.